Surgical management of lymphedema: prophylactic and therapeutic operations.
LYMPHA
immediate lymphatic reconstruction
liposuction
lymph node transfer
lymphedema
lymphovenous anastomosis
Journal
Current breast cancer reports
ISSN: 1943-4588
Titre abrégé: Curr Breast Cancer Rep
Pays: United States
ID NLM: 101498096
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
pmc-release:
01
06
2025
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
ppublish
Résumé
Lymphedema is chronic limb swelling from lymphatic dysfunction and is currently incurable. Breast-cancer related lymphedema (BCRL) affects up to 5 million Americans and occurs in one-third of breast cancer survivors following axillary lymph node dissection. Compression remains the mainstay of therapy. Surgical management of BCRL includes excisional procedures to remove excess tissue and physiologic procedures to attempt improve fluid retention in the limb. The purpose of this review is to highlight surgical management strategies for preventing and treating breast cancer-related lymphedema. Immediate lymphatic reconstruction (ILR) is a microsurgical technique that anastomoses disrupted axillary lymphatic vessels to nearby veins at the time of axillary lymph node dissection (ALND) and has been reported to reduce lymphedema rates from 30% to 4-12%. Postsurgical lymphedema remains incurable. Surgical management of lymphedema includes excisional procedures and physiologic procedures using microsurgical technique. Immediate lymphatic reconstruction has emerged as a prophylactic strategy to prevent lymphedema in breast cancer patients.
Identifiants
pubmed: 38988994
doi: 10.1007/s12609-024-00543-4
pmc: PMC11233112
doi:
Types de publication
Journal Article
Langues
eng